Firefly Neuroscience IncAIFF
Price$1.46

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $1.8M+1,565.7% YoYTTM through 30 Jun 2026
Net Income -$9.1MTTM through 30 Jun 2026
Free Cash Flow -$7MTTM through 30 Jun 2026

Margins

Current
Gross Margin56.5%
EBITDA Margin-496.9%
Operating Margin-775.5%
Net Margin-506.2%

Returns

-145.0%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio1.43x
Net Debt-$2.8Mnet cash position
Cash & Equivalents$9.2M

Quality Metrics

Altman Z-Score-5.39
Piotroski F-Score4 / 9
FCF Margin-388.6%

Multi-Year Trend

Revenue
'17'18'21'22'23'24'25
FY2025: $1.1M
Diluted EPS
'19'20'21'22'23'24'25
FY2025: $-1.60

Dividend

No dividend

Capital Allocation

R&D Spend$1.8M
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.